Attenuation potentials of royal jelly against hydroxyurea-induced infertility through inhibiting oxidation and release of pro-inflammatory cytokines in male rats
- 24 May 2019
- journal article
- research article
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 26 (21) , 21524-21534
Abstract
Hydroxyurea (HDU), a class of antineoplastic drugs, has a powerful efficacy in the treatment of several types of malignancies. However, it has multiple adverse effects including reduced fertility, especially in males. Thus, 60 male albino rats were used to investigate the chemoprotective potentials of royal jelly on HDU-induced testicular damage. Animals were gastro-gavaged with HDU (225 or 450 mg kg−1 bw day−1) before royal jelly (100 mg kg−1 bw day−1) for 60 days. Blood samples and testicles were collected, and spermatozoon was obtained. In a dose-dependent manner, the sperm count, motility and liveability, and testosterone, GSH, and catalase concentrations were decreased in HDU groups, whereas MDA, FSH, LH, IL-6, and IFN-γ expression levels were increased. Germinal epithelium degeneration, germ cell sloughing, reduction in the number of luminal spermatozoa, interstitial congestion, and severe leukocyte infiltration besides no glandular secretion in most of the acini were identified. However, royal jelly intake in HDU-treated rats successfully improved sperm quality, hormonal and antioxidant status, and reproductive organ histoarchitecture. Thus, it could be concluded that royal jelly is endowed with antioxidative and anti-inflammatory activities and could be, therefore, used as an adjuvant remedy to improve HDU-induced male subfertility.Keywords
This publication has 45 references indexed in Scilit:
- SpermiationSpermatogenesis, 2011
- The in Vivo Toxicity of Hydroxyurea Depends on Its Direct Target CatalaseJournal of Biological Chemistry, 2010
- Adverse Effects of a Clinically Relevant Dose of Hydroxyurea Used for the Treatment of Sickle Cell Disease on Male Fertility EndpointsInternational Journal of Environmental Research and Public Health, 2009
- Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative diseaseInternal Medicine Journal, 2007
- Rat liver-mediated metabolism of hydroxyurea to nitric oxideFree Radical Biology and Medicine, 2006
- The role of IL-6 and STAT3 in inflammation and cancerEuropean Journal of Cancer, 2005
- ATM/ATR-independent inhibition of cyclin B accumulation in response to hydroxyurea in nontransformed cell lines is altered in tumour cell linesOncogene, 2003
- Involvement of Germ Cell Apoptosis in the Induction of Testicular Toxicity Following Hydroxyurea TreatmentToxicology and Applied Pharmacology, 1999
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Effects of acetaminophen and hydroxyurea on spermatogenesis and sperm chromatin structure in laboratory miceReproductive Toxicology, 1995